Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)

Leigh syndrome French Canadian type (LSFC) is a recessive neurodegenerative disease characterized by tissue-specific deficiency in cytochrome c oxidase (COX), the fourth complex in the oxidative phosphorylation system. LSFC is caused by mutations in the leucine rich pentatricopeptide repeat containi...

Full description

Bibliographic Details
Main Authors: Roselle Gélinas, Chloé Lévesque, Julie Thompson Legault, Marie-Eve Rivard, Louis Villeneuve, Catherine Laprise, John D. Rioux
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1375467/full
_version_ 1827277938144313344
author Roselle Gélinas
Chloé Lévesque
Julie Thompson Legault
Marie-Eve Rivard
Louis Villeneuve
Catherine Laprise
John D. Rioux
John D. Rioux
author_facet Roselle Gélinas
Chloé Lévesque
Julie Thompson Legault
Marie-Eve Rivard
Louis Villeneuve
Catherine Laprise
John D. Rioux
John D. Rioux
author_sort Roselle Gélinas
collection DOAJ
description Leigh syndrome French Canadian type (LSFC) is a recessive neurodegenerative disease characterized by tissue-specific deficiency in cytochrome c oxidase (COX), the fourth complex in the oxidative phosphorylation system. LSFC is caused by mutations in the leucine rich pentatricopeptide repeat containing gene (LRPPRC). Most LSFC patients in Quebec are homozygous for an A354V substitution that causes a decrease in the expression of the LRPPRC protein. While LRPPRC is ubiquitously expressed and is involved in multiple cellular functions, tissue-specific expression of LRPPRC and COX activity is correlated with clinical features. In this proof-of-principle study, we developed human induced pluripotent stem cell (hiPSC)-based models from fibroblasts taken from a patient with LSFC, homozygous for the LRPPRC*354V allele, and from a control, homozygous for the LRPPRC*A354 allele. Specifically, for both of these fibroblast lines we generated hiPSC, hiPSC-derived cardiomyocytes (hiPSC-CMs) and hepatocyte-like cell (hiPSC-HLCs) lines, as well as the three germ layers. We observed that LRPPRC protein expression is reduced in all cell lines/layers derived from LSFC patient compared to control cells, with a reduction ranging from ∼70% in hiPSC-CMs to undetectable levels in hiPSC-HLC, reflecting tissue heterogeneity observed in patient tissues. We next performed exploratory analyses of these cell lines and observed that COX protein expression was reduced in all cell lines derived from LSFC patient compared to control cells. We also observed that mutant LRPPRC was associated with altered expression of key markers of endoplasmic reticulum stress response in hiPSC-HLCs but not in other cell types that were tested. While this demonstrates feasibility of the approach to experimentally study genotype-based differences that have tissue-specific impacts, this study will need to be extended to a larger number of patients and controls to not only validate the current observations but also to delve more deeply in the pathogenic mechanisms of LSFC.
first_indexed 2024-04-24T07:44:43Z
format Article
id doaj.art-8e98851c8f244ed8b792433bcf54a932
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-24T07:44:43Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-8e98851c8f244ed8b792433bcf54a9322024-04-19T04:37:53ZengFrontiers Media S.A.Frontiers in Genetics1664-80212024-04-011510.3389/fgene.2024.13754671375467Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)Roselle Gélinas0Chloé Lévesque1Julie Thompson Legault2Marie-Eve Rivard3Louis Villeneuve4Catherine Laprise5John D. Rioux6John D. Rioux7Montreal Heart Institute, Montreal, QC, CanadaMontreal Heart Institute, Montreal, QC, CanadaMontreal Heart Institute, Montreal, QC, CanadaMontreal Heart Institute, Montreal, QC, CanadaMontreal Heart Institute, Montreal, QC, CanadaUniversité du Québec à Chicoutimi, Saguenay, QC, CanadaMontreal Heart Institute, Montreal, QC, CanadaUniversité de Montréal, Montreal, QC, CanadaLeigh syndrome French Canadian type (LSFC) is a recessive neurodegenerative disease characterized by tissue-specific deficiency in cytochrome c oxidase (COX), the fourth complex in the oxidative phosphorylation system. LSFC is caused by mutations in the leucine rich pentatricopeptide repeat containing gene (LRPPRC). Most LSFC patients in Quebec are homozygous for an A354V substitution that causes a decrease in the expression of the LRPPRC protein. While LRPPRC is ubiquitously expressed and is involved in multiple cellular functions, tissue-specific expression of LRPPRC and COX activity is correlated with clinical features. In this proof-of-principle study, we developed human induced pluripotent stem cell (hiPSC)-based models from fibroblasts taken from a patient with LSFC, homozygous for the LRPPRC*354V allele, and from a control, homozygous for the LRPPRC*A354 allele. Specifically, for both of these fibroblast lines we generated hiPSC, hiPSC-derived cardiomyocytes (hiPSC-CMs) and hepatocyte-like cell (hiPSC-HLCs) lines, as well as the three germ layers. We observed that LRPPRC protein expression is reduced in all cell lines/layers derived from LSFC patient compared to control cells, with a reduction ranging from ∼70% in hiPSC-CMs to undetectable levels in hiPSC-HLC, reflecting tissue heterogeneity observed in patient tissues. We next performed exploratory analyses of these cell lines and observed that COX protein expression was reduced in all cell lines derived from LSFC patient compared to control cells. We also observed that mutant LRPPRC was associated with altered expression of key markers of endoplasmic reticulum stress response in hiPSC-HLCs but not in other cell types that were tested. While this demonstrates feasibility of the approach to experimentally study genotype-based differences that have tissue-specific impacts, this study will need to be extended to a larger number of patients and controls to not only validate the current observations but also to delve more deeply in the pathogenic mechanisms of LSFC.https://www.frontiersin.org/articles/10.3389/fgene.2024.1375467/fullinduced pluripotent stem cellsthree germ layershepatocyte-like cellscardiomyocyte cellsdisease modelingLeigh syndrome French Canadian type
spellingShingle Roselle Gélinas
Chloé Lévesque
Julie Thompson Legault
Marie-Eve Rivard
Louis Villeneuve
Catherine Laprise
John D. Rioux
John D. Rioux
Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
Frontiers in Genetics
induced pluripotent stem cells
three germ layers
hepatocyte-like cells
cardiomyocyte cells
disease modeling
Leigh syndrome French Canadian type
title Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
title_full Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
title_fullStr Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
title_full_unstemmed Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
title_short Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)
title_sort human induced pluripotent stem cells hipscs derived cells reflect tissue specificity found in patients with leigh syndrome french canadian variant lsfc
topic induced pluripotent stem cells
three germ layers
hepatocyte-like cells
cardiomyocyte cells
disease modeling
Leigh syndrome French Canadian type
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1375467/full
work_keys_str_mv AT rosellegelinas humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT chloelevesque humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT juliethompsonlegault humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT marieeverivard humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT louisvilleneuve humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT catherinelaprise humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT johndrioux humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc
AT johndrioux humaninducedpluripotentstemcellshipscsderivedcellsreflecttissuespecificityfoundinpatientswithleighsyndromefrenchcanadianvariantlsfc